CRDF
Cardiff Oncology·NASDAQ
--
--(--)
--
--(--)
4.83 / 10
Netural
Technically, CRDF is neutral with a 4.83/10 score. The Inverted Hammer suggests a potential bullish reversal, yet Long Lower and Long Upper Shadows indicate bearish pressure. Recent candlestick patterns confirm a volatile market with no clear directional bias.
Analysis Checks(1/3)
Long Lower Shadow
Score3.07/10
Win Rate57.14%
Hist. Signals35
Avg Return-2.18%
Score3.07/10
Win Rate57.14%
Hist. Signals35
Avg Return-2.18%
Inverted Hammer
Score7.93/10
Win Rate100.00%
Hist. Signals2
Avg Return1.73%
Score7.93/10
Win Rate100.00%
Hist. Signals2
Avg Return1.73%
Long Upper Shadow
Score3.49/10
Win Rate55.56%
Hist. Signals45
Avg Return-0.68%
Score3.49/10
Win Rate55.56%
Hist. Signals45
Avg Return-0.68%
Long Lower Shadow
Score3.07/10
Win Rate57.14%
Hist. Signals35
Avg Return-2.18%
Score3.07/10
Win Rate57.14%
Hist. Signals35
Avg Return-2.18%
Long Upper Shadow
Score3.49/10
Win Rate55.56%
Hist. Signals45
Avg Return-0.68%
Score3.49/10
Win Rate55.56%
Hist. Signals45
Avg Return-0.68%
Inverted Hammer
Score7.93/10
Win Rate100.00%
Hist. Signals2
Avg Return1.73%
Score7.93/10
Win Rate100.00%
Hist. Signals2
Avg Return1.73%
Technical Analysis of CRDF?
- CRDF presents a Netural setup with a Technical Score of 4.83/10. Key technical indicators highlight an RSI of 30.93 and a MACD of -0.22, with the trend anchored by the 50-Day SMA at 2.48. Traders should monitor key support at 1.45 and resistance at 1.55.
